This Startup Wants To Catch Cancer Before It Spreads
Billion to One, founded by two PhD students, has developed ultra-sensitive genetic testing technology that detects rare DNA signals in blood—such as fetal DNA during pregnancy or tumor DNA in cancer—with unprecedented precision, enabling non-invasive prenatal screening and a path toward e
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Products & Tools
Topics
Listen to This Episode
More from Y Combinator Startup Podcast
Inside The Startup Reinventing America’s Trillion Dollar Chemical Industry
Inside The Startup Building Reusable Rockets
How To Get Your First Customers
The Future Of Brain-Computer Interfaces with Science's Max Hodak
This Startup Secretly Detects Fraud For Fortune 500s
The Playbook For Building An AI Native Company
Related episodes
From other shows on similar topics.
Sell One Level Up to Scale Faster | Ep 942
The Game with Alex Hormozi
The French Industrialist Betting on Robotics to Cure Disease (And the Ethical Line He Won’t Cross) | Ep. 316 with Hervé de Malliard President of Maison MGA
Founder's Story
Fertility Inc.: The Embryo Editing Dinner
The Journal.
664. Are Thousands of Medical Cures Hiding in Plain Sight?
Freakonomics Radio
Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson
Huberman Lab
$10M Business ideas w/ The Most Interesting Guy In Tech
My First Million
Get summaries like this every morning.
Free AI-powered recaps of Y Combinator Startup Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.